生物药物用于慢性鼻炎的基于病变的应用:当前和未来的前景
Mitsuhiro Okano1, Kengo Kanai1, Aiko Oka1
1Department of Otorhinolaryngology, International University School of Medicine, Narita, Japan.
Auris, nasus, larynx
|September 24, 2023
概括
生物学显示严重的慢性鼻炎与鼻息肉 (CRSwNP) 的希望. 需要进一步的研究来优化它们的使用,并确定生物标志物,以对这种复杂疾病进行个性化治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性鼻炎 (CRS) 呈现异质病原体,包括1,2,3型炎症.
- 严重的2型CRS,特别是带鼻息肉的CRS (CRSwNP),已经看到有针对性的生物疗法的进展.
研究的目的:
- 审查生物药物的有效性在严重的CRSwNP.
- 确定未来的研究方向,以优化CRS中的生物疗法.
主要方法:
- 已完成和正在进行的CRSwNP中生物药物3期临床试验的审查.
- 分析当前的治疗算法和未来的研究需求.
主要成果:
- 针对炎症途径的几种生物药物 (例如,抗IgE,抗IL-5,抗IL-5Rα,抗IL-4Rα) 在严重CRSwNP的第三阶段试验中显示出有效性.
- 目前正在进行的tzepelumab (抗TSLP) 和etokimab (抗IL-33) 的试验进一步扩大了治疗选择.
结论:
- 生物药物在管理严重的CRSwNP方面取得了重大进展.
- 未来的研究应该集中在最佳和具有成本效益的生物利用,生物标志物识别,定义缓解标准,并通过先进的基础研究 (内型,基因型) 探索新的治疗点.
相关概念视频
Drugs Used in Upper Respiratory Disorders: Overview
279
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
279
Drug Delivery: Miscellaneous Routes
371
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
371
Drugs Used in Lower Respiratory Disorders: Overview
474
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
474
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
Inflammatory Bowel Disease IV: Pharmacological Management
145
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
145
Chronic Pharyngitis
2.6K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
2.6K


